Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus. The investigation concerns whether Simulations Plus or certain of its officers and directors made false or misleading statements or failed to disclose material information about the company's financial outlook, reporting practices, internal controls, and related accounting matters. On June 11, 2025, Simulations Plus reduced its full-year fiscal 2025 revenue guidance to a range of $76 million to $80 million, down from the previously maintained $90 million to $93 million, citing market uncertainties affecting pharmaceutical and biotechnology customers. Following this announcement, the stock fell more than 24% from $26.44 to $20.05 per share. On July 14, 2025, the company reported a net loss of $67.3 million, including a $77.2 million non-cash impairment charge, and the next day disclosed the dismissal of its auditor Grant Thornton LLP, which later filed a letter with the SEC disagreeing with aspects of the disclosure and stating that matters relating to segment reporting, reporting-unit determinations, and internal control over financial reporting were not resolved to its satisfaction. After these disclosures, shares fell nearly 26% from $17.47 to $12.97 per share. Investors who purchased Simulations Plus securities and suffered losses are encouraged to contact Johnson Fistel.
Simulations Plus IncInvestigation for potential securities law violations and false/misleading statements regarding financial outlook and internal controls.